Paradigm Biopharmaceuticals (Paradigm Biopharmaceuticals) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Paradigm Biopharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Paradigm Biopharmaceuticals's Free Cash Flow for the six months ended in Dec. 2023 was $-34.15 Mil. Paradigm Biopharmaceuticals's Revenue for the six months ended in Dec. 2023 was $0.00 Mil. Therefore, Paradigm Biopharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Paradigm Biopharmaceuticals's current FCF Yield % is -82.94%.

The historical rank and industry rank for Paradigm Biopharmaceuticals's FCF Margin % or its related term are showing as below:

PBIGF' s FCF Margin % Range Over the Past 10 Years
Min: -187725 Med: -96140.43 Max: -40765.82
Current: -187725

During the past 8 years, the highest FCF Margin % of Paradigm Biopharmaceuticals was -40765.82%. The lowest was -187725.00%. And the median was -96140.43%.

PBIGF's FCF Margin % is ranked worse than
98.56% of 1045 companies
in the Biotechnology industry
Industry Median: -143.92 vs PBIGF: -187725.00

Paradigm Biopharmaceuticals FCF Margin % Historical Data

The historical data trend for Paradigm Biopharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paradigm Biopharmaceuticals FCF Margin % Chart

Paradigm Biopharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

-167,050.00

-40,414.29

-94,768.75

Paradigm Biopharmaceuticals Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial												-37,393.75	-45,316.67	-399,333.33	-65,753.57	-

Competitive Comparison of Paradigm Biopharmaceuticals's FCF Margin %

For the Biotechnology subindustry, Paradigm Biopharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paradigm Biopharmaceuticals's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Paradigm Biopharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Paradigm Biopharmaceuticals's FCF Margin % falls into.

Paradigm Biopharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Paradigm Biopharmaceuticals's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-30.326	/	0.032
	=	-94,768.75 %

Paradigm Biopharmaceuticals's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-34.152	/	0
	=	%

Paradigm Biopharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Paradigm Biopharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Paradigm Biopharmaceuticals (Paradigm Biopharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Paradigm Biopharmaceuticals Ltd (OTCPK:PBIGF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

PAR:Australia

Address

500 Collins Street, Level 15, Melbourne, VIC, AUS, 3000

Website

https://www.paradigmbiopharma.com

Paradigm Biopharmaceuticals Ltd is a biopharmaceutical company that engages in the research and development of therapeutic products for human use in Australia. The firm is engaged in drug repurposing, pentosan polysulphate sodium (PPS) for the lead clinical indication of bone marrow edema, Alphavirus - Ross River virus (RRV) and Chikungunya virus (CHIKV), Mucopolysaccharidosis, and allergic respiratory conditions, including allergic rhinitis (AR) and chronic obstructive pulmonary disease (COPD).